Demo Day

Demo Day is a pitch event and the culmination of VelocityTX most recent BioGlobal Accelerator Program. Companies will showcase their milestones and successes to an audience of over 200 bioscience community members, investors, industry experts and innovators.

Meet The 2022 Cohort

Biomedical Development Corporation |

Biomedical Development Corporation is developing KIOS, a digital health therapeutic for the treatment of opioid use disorder (OUD). KIOS will be an FDA-approved digital therapeutic medical device used adjunctively to medication assisted therapy. In contrast to other digital products for OUD, only KIOS offers continuously available, individualized, evidence-based behavioral intervention strategies responsive to a patient’s evolving clinical status outside the context of the doctor’s office or treatment facility.

Life SI |

Life SI is devoted to the development of technology for health-research, mainly 3D Bioprinting and Microfluidics. One of the main goals is to create human tissue do transplant in real-life patients. Life SI’s product is mainly aimed to research instituitions such as universities working on reseach for health applications.

Dialectra by Powell Medical Innovations

Powell Medical Innovations is a start up focused on creating and investing in new medical technologies. This company is unique in the field because the founding members are composed are not associated with a physicians group or biotech company, but rather just two individuals with fresh ideas.

The only product currently under the ownership of Powell Medical Innovations is Dialectra, a sensing apparatus for peritoneal dialysis patients.

Savidj |

Savidj is a neurological health technology company developing software for use in off-the-shelf XR devices. We are also developing a Faceguard, which can be embedded with our software, to be used in contact sports, to detect concussions.

Savidj is devoted to the detection, monitoring, and improvement of neurological health through our proprietary eye-tracking & head movement software. 

Their goal is to detect neurological disorders such as concussions or Alzheimer’s Disease, early in order to begin rapid treatment and prevent further impairments.

Thank you to our 2022 Demo Day Sponsors

Title Sponsor

Track Sponsors

Jefferson Bank - stacked centered logo

Investing SponsorS

Supporting Sponsors

Meet The 2021 Cohort

Alt-Bionics | Texas |

Alt-Bionics is applying new, advanced, and low-cost technology to medical prosthetic devices to display the capabilities that are similar in both form and function to higher-priced devices.  

Bioxiplas | Chile |

Manufactures and commercializes biodegradable personal disposable equipment, compostable and biodegradable plastic bags, and a new patented line of anti-viral (SARS COV2) material. 

Eisana | Texas |

An oncology solution company providing products to solve the unmet needs resulting from cancer treatment. While cancer survival continues to improve, side effects remain significant in terms of reduced quality of life and healthcare cost.

Neurognos | Chile |

Is developing a noninvasive and simple disease diagnostic strategy for early Alzheimer’s screening, utilizing cutting-edge miRNA and Machine Learning technology. 

Olifant Medical Inc. | Texas

Is developing and commercializing novel medical device solutions for healthcare workers’ technical challenges, creating better patient-provider experiences, leading to better outcomes for patients, and saving lives. 

Thummi | Brazil |

Is an application that records and organizes the patient’s day-to-day events and provides real-time reports to clinics and doctors, to improve patient quality of life. 

Incubator Program

The Incubator Program is designed to scale early-stage bioscience companies by providing long-term support and includes office and meeting space, access to industry experts, mentors, and more.

CEO Roundtable

The CEO Roundtable is an exclusive membership program that brings together executives from non-competing bioscience and healthcare companies to foster innovation, collaboration, and connections.